Skip to content
CACA·WikiThe living current-affairs record
--:--:--to drop
Sign in
Economy & Bankingv2 · 2 versions

India's Pharmaceutical Sector

India is the world's pharmacy - third by volume, first in generics, and a USD 60 billion market aiming to more than double by 2030. Its weak spot is inputs: for many essential chemicals it still leans on China. The current policy push runs on two tracks - money to build ingredient capacity at home, and a tighter grip on drug approvals.

Last updated 7 August 20267 min read
Latest update
Added the new debarment penalty - licensing authorities can now bar applicants who file fake or fabricated data, on top of rejection or licence cancellation - and restructured the card for faster reading.

Read the full living note — free

The complete note in both exam lenses (UPSC analytical / fact capsule), its full version history, and “what changed since you last read” — plus tonight's quiz.

Open in CA·Wiki

AI-assisted, human-reviewed · sourced from PIB, RBI & ministries · editorial policy

More living notes in Economy & Banking

Browse all topics →

India's Pharmaceutical Sector — Economy & Banking current affairs | CA·Wiki